BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 3643793)

  • 1. Identification of a new tissue-kallikrein-binding protein.
    Chao J; Tillman DM; Wang MY; Margolius HS; Chao L
    Biochem J; 1986 Oct; 239(2):325-31. PubMed ID: 3643793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A major difference of kallikrein-binding protein in spontaneously hypertensive versus normotensive rats.
    Chao J; Chao L
    J Hypertens; 1988 Jul; 6(7):551-7. PubMed ID: 3171170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential interactions of human kallikrein-binding protein and alpha 1-antitrypsin with human tissue kallikrein.
    Chen LM; Chao L; Mayfield RK; Chao J
    Biochem J; 1990 Apr; 267(1):79-84. PubMed ID: 2327990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kallistatin: a novel human tissue kallikrein inhibitor. Purification, characterization, and reactive center sequence.
    Zhou GX; Chao L; Chao J
    J Biol Chem; 1992 Dec; 267(36):25873-80. PubMed ID: 1334488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inactivation of kallikrein in human plasma.
    van der Graaf F; Koedam JA; Bouma BN
    J Clin Invest; 1983 Jan; 71(1):149-58. PubMed ID: 6184384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human kallistatin, a new tissue kallikrein-binding protein: purification and characterization.
    Wang MY; Day J; Chao L; Chao J
    Adv Exp Med Biol; 1989; 247B():1-8. PubMed ID: 2558505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High molecular weight kininogen potentiates the heparin-accelerated inhibition of plasma kallikrein by antithrombin: role for antithrombin in the regulation of kallikrein.
    Olson ST; Sheffer R; Francis AM
    Biochemistry; 1993 Nov; 32(45):12136-47. PubMed ID: 7692967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and characterization of rat kallikrein-binding protein in Escherichia coli.
    Ma JX; Chao L; Zhou G; Chao J
    Biochem J; 1993 Jun; 292 ( Pt 3)(Pt 3):825-32. PubMed ID: 8318011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human plasma alpha 2-macroglobulin. An inhibitor of plasma kallikrein.
    Harpel PC
    J Exp Med; 1970 Aug; 132(2):329-52. PubMed ID: 4101346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of tissue kallikrein by protein C inhibitor. Evidence for identity of protein C inhibitor with the kallikrein binding protein.
    Ecke S; Geiger M; Resch I; Jerabek I; Sting L; Maier M; Binder BR
    J Biol Chem; 1992 Apr; 267(10):7048-52. PubMed ID: 1313031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo catabolism of human kallikrein-binding protein and its complex with tissue kallikrein.
    Xiong W; Tang CQ; Zhou GX; Chao L; Chao J
    J Lab Clin Med; 1992 May; 119(5):514-21. PubMed ID: 1583408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reactive-site specificity of human kallistatin toward tissue kallikrein probed by site-directed mutagenesis.
    Chen VC; Chao L; Chao J
    Biochim Biophys Acta; 2000 Jun; 1479(1-2):237-46. PubMed ID: 10862973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue kallikrein-binding protein is a serpin. I. Purification, characterization, and distribution in normotensive and spontaneously hypertensive rats.
    Chao J; Chai KX; Chen LM; Xiong W; Chao S; Woodley-Miller C; Wang LX; Lu HS; Chao L
    J Biol Chem; 1990 Sep; 265(27):16394-401. PubMed ID: 2398056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification of enzymatically active kallikrein hK2 from human seminal plasma.
    Frenette G; Deperthes D; Tremblay RR; Lazure C; Dubé JY
    Biochim Biophys Acta; 1997 Feb; 1334(1):109-15. PubMed ID: 9042371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible identity of kallikrein binding protein with protein C inhibitor.
    Ecke S; Geiger M; Resch I; Jerabek I; Maier M; Binder BR
    Agents Actions Suppl; 1992; 38 ( Pt 1)():182-9. PubMed ID: 1334618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human glandular kallikrein, hK2, shows arginine-restricted specificity and forms complexes with plasma protease inhibitors.
    Mikolajczyk SD; Millar LS; Kumar A; Saedi MS
    Prostate; 1998 Jan; 34(1):44-50. PubMed ID: 9428387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of human plasma kallikrein and its light chain with C1 inhibitor.
    van der Graaf F; Koedam JA; Griffin JH; Bouma BN
    Biochemistry; 1983 Sep; 22(20):4860-6. PubMed ID: 6556071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. alpha2-macroglobulin and C1-inactivator are plasma inhibitors of human glandular kallikrein.
    Heeb MJ; España F
    Blood Cells Mol Dis; 1998 Dec; 24(4):412-9. PubMed ID: 9851894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunochemical studies of plasma kallikrein.
    Bagdasarian A; Lahiri B; Talamo RC; Wong P; Colman RW
    J Clin Invest; 1974 Dec; 54(6):1444-54. PubMed ID: 4140197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution of plasma kallikrein between C-1 inactivator and alpha 2-macroglobulin in plasma utilizing a new assay for alpha 2-macroglobulin-kallikrein complexes.
    Harpel PC; Lewin MF; Kaplan AP
    J Biol Chem; 1985 Apr; 260(7):4257-63. PubMed ID: 2579948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.